Stay updated on ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The site’s footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T22:16:14.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:10:02.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden message, blocking access to the study record; previously visible study-related content such as contact information, documents, and location details is no longer displayed.
    Difference
    20%
    Check dated 2026-09-19T22:25:25.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, updating the site’s version tag from v3.6.5. This reflects a backend/platform update and does not modify the study data or user-facing content.
    Difference
    0.0%
    Check dated 2026-08-29T20:42:34.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.4 to v3.6.5, indicating a newer build of the Study Details page. This behind-the-scenes update does not modify the displayed content or study results.
    Difference
    0.0%
    Check dated 2026-08-08T17:07:46.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing Revision: v3.6.3. This indicates a new site release without changes to study content.
    Difference
    0.0%
    Check dated 2026-07-25T10:23:52.000Z thumbnail image

Stay in the know with updates to ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.